SWOG clinical trial number
SWOG-8519

Phase II Evaluation of Methyl-Glyoxal Bis- Guanylhydrazone (MGBG) in Patients With Advanced Bladder Cancer

Closed
Phase
Published
Abbreviated Title
Phase II Evaluation of Methyl-Glyoxal Bis- Guanylhydrazone (MGBG) in Patients With Advanced Bladder Cancer
Activated
01/01/1986
Closed
05/15/1989

Publication Information Expand/Collapse

1990

Methyl-glyoxal bis-guanylhydrazone (MGBG) in advanced bladder cancer.

DD Von Hoff;B Blumenstein;TW Pollock;ED Crawford;JK Weick;JT Guy;M Eisenberger;WS Fletcher;RB Natale EJC 26(7):848-849